Ross Erwin McKinney Jr.
Professor Emeritus of Pediatrics
RESEARCH ABSTRACT
Dr. Ross McKinney's research is in the antiretroviral treatment of HIV infected children, and he has additionally published articles on the natural history and pathogenesis of pediatric HIV disease. Dr. McKinney chaired Pediatric AIDS Clinical Trials Group Protocol 300, a large (600 patient) study of zidovudine, didanosine, and lamivudine in HIV infected children. He recently Co-chaired PACTG 1021 (A phase I-II study of FTC, DDI, and efavirenz), and PACTG 390/PenPact 1 (an international study of treatment strategies for therapy naive children). Dr. McKinney also cochaired PACTG 247, a study of nutritional supplementation in HIV exposed and infected infants.
As of July 2007, Dr. McKinney became the director of the Trent Center for Bioethics, Humanities, and History of Medicine in the Duke University School of Medicine. His current research involves the ethics of medical research, with a particular focus on conflict of interest and on the informed consent process.
Dr. Ross McKinney's research is in the antiretroviral treatment of HIV infected children, and he has additionally published articles on the natural history and pathogenesis of pediatric HIV disease. Dr. McKinney chaired Pediatric AIDS Clinical Trials Group Protocol 300, a large (600 patient) study of zidovudine, didanosine, and lamivudine in HIV infected children. He recently Co-chaired PACTG 1021 (A phase I-II study of FTC, DDI, and efavirenz), and PACTG 390/PenPact 1 (an international study of treatment strategies for therapy naive children). Dr. McKinney also cochaired PACTG 247, a study of nutritional supplementation in HIV exposed and infected infants.
As of July 2007, Dr. McKinney became the director of the Trent Center for Bioethics, Humanities, and History of Medicine in the Duke University School of Medicine. His current research involves the ethics of medical research, with a particular focus on conflict of interest and on the informed consent process.
Current Appointments & Affiliations
- Professor Emeritus of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2016
Contact Information
- Box 3461 Med Ctr, Durham, NC 27710
- Seeley Mudd Building, Room 108, Durham, NC 27710
-
ross.mckinney@duke.edu
(919) 668-9000
- Background
-
Education, Training, & Certifications
- M.D., University of Rochester 1979
-
Previous Appointments & Affiliations
- Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2007 - 2016
- Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2009 - 2016
- Associate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2015 - 2016
- Affiliate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2014 - 2015
- Professor of Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2007 - 2010
- Interim Chair, Department of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2005 - 2007
- Vice Dean for Research in the School of Medicine, School of Medicine, Duke University 2002 - 2007
- Associate Professor of Pediatrics with Tenure, Pediatrics, Infectious Diseases, Pediatrics 1997 - 2007
- Assistant Professor of Virology in the Department of Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2002 - 2007
- Chief, Division of Infectious Diseases in the Department of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 1994 - 2003
- Assistant Professor of Virology in the Department of Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 1994 - 2002
- Associate Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 1994 - 1997
- Assistant Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 1987 - 1994
- Associate in the Department of Pediatrics, Pediatrics, Clinical Science Departments 1985 - 1987
- Recognition
-
In the News
- Research
-
Selected Grants
- Health Care Systems Research Collaboratory - Coordinating Center awarded by National Institutes of Health 2012 - 2019
- Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
- AIDS International Training and Research Program awarded by National Institutes of Health 2003 - 2014
- PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS awarded by National Institutes of Health 2009 - 2013
- CORE / DUMC Pediatric Clinical Research Site (CRS) 1U01AI69484-01 awarded by National Institutes of Health 2007 - 2013
- Finding Consciousness Workshop awarded by National Institutes of Health 2012 - 2013
- CTSA UL awarded by National Institutes of Health 2006 - 2012
- North Carolina Collaborative PPRU Network awarded by National Institutes of Health 2004 - 2010
- Nitroprusside in Children (NITPIC) awarded by National Institutes of Health 2004 - 2010
- NIH National Research Service Award Institutional Research Training Grant (T32) Duke Pediatric Cardiology awarded by National Institutes of Health 2004 - 2009
- HIV/AIDS Clinical Trials Unit (IMPAACT CTU) awarded by National Institutes of Health 2007 - 2008
- IMPAACT CTU awarded by National Institutes of Health 2007 - 2008
- COI - Conflict of Interest White Paper / Compendia I awarded by Agency for Healthcare Research and Quality 2008
- Pediatrics AIDS Clincial Trials Unit awarded by National Institutes of Health 1998 - 2007
- Integrated Human Research Subjects Protection Project awarded by National Institutes of Health 2003 - 2005
- Clinical Predictors of Antiretroviral Failure awarded by National Institutes of Health 2002 - 2004
- Advanced Nurse Education Program: Pediatric Acute Care Nurse Practitioner Program awarded by Department of Health and Human Services 1999 - 2002
- Pediatric Aids Clinical Trials Unit awarded by National Institutes of Health 1997 - 1999
- Pediatric Aids Clinical Trials Unit awarded by National Institutes of Health 1995 - 1997
- Pediatric Aids Clinical Trials Program awarded by National Institutes of Health 1993 - 1997
- Pediatric Aids Clinical Trials Unit awarded by National Institutes of Health 1989 - 1997
- Pediatric Aids Treatment Group awarded by National Institutes of Health 1993
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
McKinney, Ross E., Norma Poll-Hunter, and Lisa D. Howley. “The Current State of Efforts to Address Disparities, Racism and Cultural Humility in Medical Education.” Am J Bioeth 21, no. 9 (September 2021): 1–3. https://doi.org/10.1080/15265161.2021.1956637.Full Text Link to Item
-
McKinney, Ross E. “Why Have Uniform Informed Consent Documents When the Research Volunteers Are So Diverse?” Am J Bioeth 21, no. 5 (May 2021): 59–60. https://doi.org/10.1080/15265161.2021.1907001.Full Text Link to Item
-
Andriole, Dorothy A., Douglas Grbic, Jodi Yellin, and Ross McKinney. “MD-PhD Program Graduates' Engagement in Research: Results of a National Study.” Acad Med 96, no. 4 (April 1, 2021): 540–48. https://doi.org/10.1097/ACM.0000000000003516.Full Text Link to Item
-
McKinney, Ross E. “Improving Comparative Effectiveness Trials.” Am J Bioeth 20, no. 1 (January 2020): 40–42. https://doi.org/10.1080/15265161.2019.1687788.Full Text Link to Item
-
Yin, Dwight E., Christina Ludema, Stephen R. Cole, Carol E. Golin, William C. Miller, Meredith G. Warshaw, Ross E. McKinney, and Ross E. PENPACT-1 (PENTA 9 / PACTG 390) Study Team. “Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.” Plos One 15, no. 11 (2020): e0242405. https://doi.org/10.1371/journal.pone.0242405.Full Text Link to Item
-
Flores, Dalmacio, Sharron L. Docherty, Michael V. Relf, Ross E. McKinney, and Julie V. Barroso. “"It's Almost Like Gay Sex Doesn't Exist:" Parent-Child Sex Communication According to Gay, Bisexual, and Queer Adolescent Sons.” J Adolesc Res 34, no. 5 (September 1, 2019): 528–62. https://doi.org/10.1177/0743558418757464.Full Text Link to Item
-
McKinney, Ross E. “Clinical Research Is a Team Sport.” Am J Bioeth 19, no. 4 (April 2019): 22–23. https://doi.org/10.1080/15265161.2019.1574494.Full Text Link to Item
-
McKinney, Ross E. “Serious Ethical Violations by Physicians: What's the Solution?” Am J Bioeth 19, no. 1 (January 2019): 11–12. https://doi.org/10.1080/15265161.2018.1552037.Full Text Link to Item
-
McKinney, Ross E. “In Reply to Fochtmann.” Acad Med 93, no. 4 (April 2018): 518. https://doi.org/10.1097/ACM.0000000000002125.Full Text Link to Item
-
Flores, Dalmacio, Ross McKinney, Joyell Arscott, and Julie Barroso. “Obtaining waivers of parental consent: A strategy endorsed by gay, bisexual, and queer adolescent males for health prevention research.” Nurs Outlook 66, no. 2 (March 2018): 138–48. https://doi.org/10.1016/j.outlook.2017.09.001.Full Text Link to Item
-
McKinney, Ross E. “The Daunting Career of the Physician-Investigator.” Acad Med 92, no. 10 (October 2017): 1368–70. https://doi.org/10.1097/ACM.0000000000001869.Full Text Link to Item
-
Pierce, Heather H., and Ross E. McKinney. “Opportunities Missed and Created by the New Common Rule.” Am J Bioeth 17, no. 7 (July 2017): 36–38. https://doi.org/10.1080/15265161.2017.1328541.Full Text Link to Item
-
McKinney, Ross E., and Heather H. Pierce. “Strategies for Addressing a Broader Definition of Conflicts of Interest.” Jama 317, no. 17 (May 2, 2017): 1727–28. https://doi.org/10.1001/jama.2017.3857.Full Text Link to Item
-
McKinney, Ross E. “Institutional Conflict of Interest-Reply.” Jama Ophthalmol 134, no. 11 (November 1, 2016): 1335. https://doi.org/10.1001/jamaophthalmol.2016.3250.Full Text Link to Item
-
McKinney, Ross. “Being Right Isn't Always Enough: NFL Culture and Team Physicians' Conflict of Interest.” Hastings Cent Rep 46 Suppl 2 (November 2016): S33–34. https://doi.org/10.1002/hast.655.Full Text Link to Item
-
Adler, R. A., G. El-Hajj Fuleihan, D. C. Bauer, P. M. Camacho, B. L. Clarke, G. A. Clines, J. E. Compston, et al. “Corrigendum to: Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research (J Bone Miner Res, (2016), 31, (16-35), 10.1002/jbmr.2708).” Journal of Bone and Mineral Research 31, no. 10 (October 1, 2016): 1910. https://doi.org/10.1002/jbmr.2918.Full Text
-
Hallinan, Zachary P., Annemarie Forrest, Gina Uhlenbrauck, Sheila Young, and Ross McKinney. “Barriers to Change in the Informed Consent Process: A Systematic Literature Review.” Irb 38, no. 3 (May 2016): 1–10.Link to Item
-
McKinney, Ross E. “Institutional Conflict of Interest and the Translational Pathway.” Jama Ophthalmol 134, no. 5 (May 1, 2016): 483–84. https://doi.org/10.1001/jamaophthalmol.2016.0459.Full Text Link to Item
-
Adler, Robert A., Ghada El-Hajj Fuleihan, Douglas C. Bauer, Pauline M. Camacho, Bart L. Clarke, Gregory A. Clines, Juliet E. Compston, et al. “Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.” J Bone Miner Res 31, no. 1 (January 2016): 16–35. https://doi.org/10.1002/jbmr.2708.Full Text Link to Item
-
McKinney, Ross E., Laura M. Beskow, Daniel E. Ford, John D. Lantos, Jonathan McCall, Bray Patrick-Lake, Mark J. Pletcher, Brian Rath, Hollie Schmidt, and Kevin Weinfurt. “Use of altered informed consent in pragmatic clinical research.” Clin Trials 12, no. 5 (October 2015): 494–502. https://doi.org/10.1177/1740774515597688.Full Text Link to Item
-
Harrison, Linda, Ann Melvin, Susan Fiscus, Yacine Saidi, Eleni Nastouli, Lynda Harper, Alexandra Compagnucci, et al. “HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.” J Acquir Immune Defic Syndr 70, no. 1 (September 1, 2015): 42–53. https://doi.org/10.1097/QAI.0000000000000671.Full Text Link to Item
-
McKinney, Ross E. “A Knotty Problem of Intertwined Rights.” Am J Bioeth 15, no. 10 (2015): 60–61. https://doi.org/10.1080/15265161.2015.1075799.Full Text Link to Item
-
Gerardo, Charles J., Eric J. Lavonas, and Ross E. McKinney. “Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation.” Clin Trials 11, no. 5 (October 2014): 560–64. https://doi.org/10.1177/1740774514543538.Full Text Link to Item
-
Yin, Dwight E., Meredith G. Warshaw, William C. Miller, Hannah Castro, Susan A. Fiscus, Lynda M. Harper, Linda J. Harrison, et al. “Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.” Pediatrics 134, no. 4 (October 2014): e1104–16. https://doi.org/10.1542/peds.2014-0527.Full Text Link to Item
-
Limkakeng, Alexander T., Lucas Lentini Herling de Oliveira, Tais Moreira, Amruta Phadtare, Clarissa Garcia Rodrigues, Michael B. Hocker, Ross McKinney, Corrine I. Voils, and Ricardo Pietrobon. “Systematic review and metasummary of attitudes toward research in emergency medical conditions.” J Med Ethics 40, no. 6 (June 2014): 401–8. https://doi.org/10.1136/medethics-2012-101147.Full Text Open Access Copy Link to Item
-
Shane, Elizabeth, David Burr, Bo Abrahamsen, Robert A. Adler, Thomas D. Brown, Angela M. Cheung, Felicia Cosman, et al. “Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.” J Bone Miner Res 29, no. 1 (January 2014): 1–23. https://doi.org/10.1002/jbmr.1998.Full Text Link to Item
-
Freedman, Ralph S., and Ross McKinney. “Is conflict of interest becoming a challenge for institution-based institutional review boards?” Clin Cancer Res 19, no. 15 (August 1, 2013): 4034–39. https://doi.org/10.1158/1078-0432.CCR-13-0543.Full Text Link to Item
-
Wilfond, Benjamin S., David Magnus, Armand H. Antommaria, Paul Appelbaum, Judy Aschner, Keith J. Barrington, Tom Beauchamp, et al. “The OHRP and SUPPORT.” N Engl J Med 368, no. 25 (June 20, 2013): e36. https://doi.org/10.1056/NEJMc1307008.Full Text Link to Item
-
McKinney, Ross E. “Let the punishment fit the crime: sensible consent in the management of human subjects research and standard-of-care interventions.” Am J Bioeth 13, no. 12 (2013): 22–23. https://doi.org/10.1080/15265161.2013.849311.Full Text Link to Item
-
Testoni, Daniela, Christoph P. Hornik, P Brian Smith, Daniel K. Benjamin, and Ross E. McKinney. “Sports medicine and ethics.” Am J Bioeth 13, no. 10 (2013): 4–12. https://doi.org/10.1080/15265161.2013.828114.Full Text Link to Item
-
Tremoulet, Adriana H., Mina Nikanjam, Tim R. Cressey, Kulkanya Chokephaibulkit, Ross McKinney, Mark Mirochnick, and Edmund V. Capparelli. “Developmental pharmacokinetic changes of Lamivudine in infants and children.” J Clin Pharmacol 52, no. 12 (December 2012): 1824–32. https://doi.org/10.1177/0091270011426563.Full Text Link to Item
-
Lichter, Allen S., and Ross McKinney. “Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiative.” Jama 308, no. 20 (November 28, 2012): 2093–94. https://doi.org/10.1001/jama.2012.51172.Full Text Link to Item
-
Eisman, John A., Earl R. Bogoch, Rick Dell, J Timothy Harrington, Ross E. McKinney, Alastair McLellan, Paul J. Mitchell, et al. “Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention.” J Bone Miner Res 27, no. 10 (October 2012): 2039–46. https://doi.org/10.1002/jbmr.1698.Full Text Link to Item
-
Tereskerz, P. M., R. Edelman, and R. McKinney. “Clinical Research and the Law.” Clinical Research and the Law, April 24, 2012. https://doi.org/10.1002/9781118272152.Full Text
-
Shane, E., D. Burr, P. R. Ebeling, B. Abrahamsen, R. A. Adler, T. D. Brown, A. M. Cheung, et al. “Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)).” Journal of Bone and Mineral Research 26, no. 8 (August 1, 2011): 1987. https://doi.org/10.1002/jbmr.416.Full Text
-
Harrison, L., A. Babiker, H. Castro, A. Compagnucci, S. Fiscus, C. Giaquinto, D. M. Gibb, et al. “First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial.” The Lancet Infectious Diseases 11, no. 4 (April 1, 2011): 273–83. https://doi.org/10.1016/S1473-3099(10)70313-3.Full Text
-
Shane, Elizabeth, David Burr, Peter R. Ebeling, Bo Abrahamsen, Robert A. Adler, Thomas D. Brown, Angela M. Cheung, et al. “Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.” J Bone Miner Res 25, no. 11 (November 2010): 2267–94. https://doi.org/10.1002/jbmr.253.Full Text Link to Item
-
Winter, Harland S., James M. Oleske, Michael D. Hughes, Ross E. McKinney, Carol Elgie, Christine Powell, Lynette Purdue, et al. “Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.” J Pediatr Gastroenterol Nutr 49, no. 2 (August 2009): 222–32. https://doi.org/10.1097/MPG.0b013e3181928937.Full Text Link to Item
-
Weinberg, Adriana, Ruth Dickover, Paula Britto, Chengcheng Hu, Julie Patterson-Bartlett, Joyce Kraimer, Howard Gutzman, et al. “Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.” Aids 22, no. 17 (November 12, 2008): 2267–77. https://doi.org/10.1097/QAD.0b013e3283189bb3.Full Text Link to Item
-
McKinney, Ross E., John Rodman, Chengcheng Hu, Paula Britto, Michael Hughes, Mary Elizabeth Smith, Leslie K. Serchuck, et al. “Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.” Pediatrics 120, no. 2 (August 2007): e416–23. https://doi.org/10.1542/peds.2006-0925.Full Text Link to Item
-
McKinney, R. “Antiretroviral therapy,” January 1, 2006, 335–59. https://doi.org/10.1017/CBO9780511544781.013.Full Text
-
McKinney, Ross, and David Korn. “Should an institution that has commercial rights in a new drug or device be allowed to evaluate the technology?” Plos Med 2, no. 1 (January 2005): e9. https://doi.org/10.1371/journal.pmed.0020009.Full Text Link to Item
-
Benjamin, Daniel K., Steven Hirschfeld, Coleen K. Cunningham, and Ross E. McKinney. “Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials.” J Antimicrob Chemother 54, no. 4 (October 2004): 701–3. https://doi.org/10.1093/jac/dkh410.Full Text Link to Item
-
Singh, Kumud K., Charlene F. Barroga, Michael D. Hughes, Jie Chen, Claire Raskino, Ross E. McKinney, and Stephen A. Spector. “Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States.” J Acquir Immune Defic Syndr 35, no. 3 (March 1, 2004): 309–13. https://doi.org/10.1097/00126334-200403010-00013.Full Text Link to Item
-
Carey, V. J., F. H. Yong, L. M. Frenkel, and R. M. McKinney. “Growth velocity assessment in paediatric AIDS: smoothing, penalized quantile regression and the definition of growth failure.” Stat Med 23, no. 3 (February 15, 2004): 509–26. https://doi.org/10.1002/sim.1578.Full Text Link to Item
-
McKinney, Ross E., and Coleen K. Cunningham. “Newer treatments for HIV in children.” Curr Opin Pediatr 16, no. 1 (February 2004): 76–79. https://doi.org/10.1097/00008480-200402000-00014.Full Text Link to Item
-
Englund, Janet A., Claire Raskino, Cindy Vavro, Paul Palumbo, Lisa L. Ross, Ross McKinney, Divna Nikolic-Djokic, Robert C. Colgrove, Carol J. Baker, and Carol J. Pediatric AIDS Clinical Trials Group Protocol 152 Team. “Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.” Pediatr Infect Dis J 23, no. 1 (January 2004): 15–22. https://doi.org/10.1097/01.inf.0000105105.80229.ba.Full Text Link to Item
-
Benjamin, D. K., W. C. Miller, R. W. Ryder, D. J. Weber, E. Walter, and R. E. McKinney. “Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings.” Aids Patient Care Stds 18, no. 1 (January 2004): 35–43. https://doi.org/10.1089/108729104322740901.Full Text Link to Item
-
Chantry, Caroline J., Robert S. Byrd, Janet A. Englund, Carol J. Baker, Ross E. McKinney, and Ross E. Pediatric AIDS Clinical Trials Group Protocol 152 Study Team. “Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection.” Pediatr Infect Dis J 22, no. 12 (December 2003): 1033–39. https://doi.org/10.1097/01.inf.0000100575.64298.bc.Full Text Link to Item
-
Dunn, David, and David HIV Paediatric Prognostic Markers Collaborative Study Group. “Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis.” Lancet 362, no. 9396 (November 15, 2003): 1605–11. https://doi.org/10.1016/s0140-6736(03)14793-9.Full Text Link to Item
-
Singh, Kumud K., Charlene F. Barroga, Michael D. Hughes, Jie Chen, Claire Raskino, Ross E. McKinney, and Stephen A. Spector. “Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.” J Infect Dis 188, no. 10 (November 15, 2003): 1461–72. https://doi.org/10.1086/379038.Full Text Link to Item
-
Benjamin, Daniel K., Wiliam C. Miller, Robert W. Ryder, David J. Weber, Emmanuel Walter, and Ross E. McKinney. “A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.” Aids 17, no. 16 (November 7, 2003): 2331–36. https://doi.org/10.1097/00002030-200311070-00007.Full Text Link to Item
-
McKinney, Ross E. “Congress, the FDA, and the fair development of new medications for children.” Pediatrics 112, no. 3 Pt 1 (September 2003): 669–70. https://doi.org/10.1542/peds.112.3.669.Full Text Link to Item
-
Capparelli, Edmund V., Janet A. Englund, James D. Connor, Stephen A. Spector, Ross E. McKinney, Paul Palumbo, and Carol J. Baker. “Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.” J Clin Pharmacol 43, no. 2 (February 2003): 133–40. https://doi.org/10.1177/0091270002239821.Full Text Link to Item
-
Capparelli, Edmund V., Mark Mirochnick, Wayne M. Dankner, Suzette Blanchard, Lynne Mofenson, George D. McSherry, Hannah Gay, et al. “Pharmacokinetics and tolerance of zidovudine in preterm infants.” J Pediatr 142, no. 1 (January 2003): 47–52. https://doi.org/10.1067/mpd.2003.mpd0335.Full Text Link to Item
-
McKinney, Ross E. “Shooting at a moving target: natural history studies and the rapidly improving state of anti-HIV treatment.” J Pediatr 141, no. 3 (September 2002): 301–2. https://doi.org/10.1067/mpd.2002.127274.Full Text Link to Item
-
Fiscus, Susan A., Adaora A. Adimora, Michele L. Funk, Victor J. Schoenbach, Deborah Tristram, Wilma Lim, Ross McKinney, David Rupar, Charles Woods, and Catherine Wilfert. “Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.” Pediatr Infect Dis J 21, no. 7 (July 2002): 664–68. https://doi.org/10.1097/00006454-200207000-00012.Full Text Link to Item
-
Johnston, A. M., M. E. Valentine, J. Ottinger, R. Baydo, V. Gryszowka, C. Vavro, K. Weinhold, M. St Clair, and R. E. McKinney. “Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.” Pediatr Infect Dis J 20, no. 10 (October 2001): 941–46. https://doi.org/10.1097/00006454-200110000-00006.Full Text Link to Item
-
Benjamin, D. K., W. C. Miller, S. A. Fiscus, M. Morse, M. Valentine, and R. E. McKinney. “Rational testing of the HIV-exposed infant.” Pediatrics 108, no. 1 (July 2001): E3. https://doi.org/10.1542/peds.108.1.e3.Full Text Link to Item
-
Benjamin, D. K., W. Miller, H. Garges, R. E. McKinney, M. Cotton, R. G. Fisher, and K. A. Alexander. “Bacteremia, central catheters, and neonates: when to pull the line.” Pediatrics 107, no. 6 (June 2001): 1272–76. https://doi.org/10.1542/peds.107.6.1272.Full Text Link to Item
-
Fisher, R. G., S. Nageswaran, M. E. Valentine, and R. E. McKinney. “Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.” Aids Patient Care Stds 15, no. 5 (May 2001): 263–69. https://doi.org/10.1089/10872910152050784.Full Text Link to Item
-
Cunningham, C. K., D. W. Wara, M. Kang, T. Fenton, E. Hawkins, J. McNamara, L. Mofenson, et al. “Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.” Clin Infect Dis 32, no. 5 (March 1, 2001): 801–7. https://doi.org/10.1086/319215.Full Text Link to Item
-
Goulder, P. J., Y. Tang, C. Brander, M. R. Betts, M. Altfeld, K. Annamalai, A. Trocha, et al. “Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.” J Exp Med 192, no. 12 (December 18, 2000): 1819–32. https://doi.org/10.1084/jem.192.12.1819.Full Text Link to Item
-
Lindsey, J. C., M. D. Hughes, R. E. McKinney, M. K. Cowles, J. A. Englund, C. J. Baker, S. K. Burchett, M. W. Kline, A. Kovacs, and J. Moye. “Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children.” J Infect Dis 182, no. 5 (November 2000): 1385–93. https://doi.org/10.1086/315865.Full Text Link to Item
-
Vavro, C. L., A. M. Zimmermann, D. R. McClernon, S. L. Kehne, L. A. Martel, M. E. Valentine, and R. E. McKinney. “Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy.” Ann N Y Acad Sci 918 (November 2000): 381–85. https://doi.org/10.1111/j.1749-6632.2000.tb05512.x.Full Text Link to Item
-
Benjamin, D. K., K. Ross, R. E. McKinney, R. Auten, and R. G. Fisher. “When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.” Pediatrics 106, no. 4 (October 2000): 712–18. https://doi.org/10.1542/peds.106.4.712.Full Text Link to Item
-
Benjamin, D. K., R. G. Fisher, and R. E. McKinney. “Candidal mycetoma in the neonatal kidney.” Pediatrics 104, no. 5 Pt 1 (November 1999): 1126–29. https://doi.org/10.1542/peds.104.5.1126.Full Text Link to Item
-
Wang, Y., E. Livingston, S. Patil, R. E. McKinney, A. D. Bardeguez, J. Gandia, M. J. O’Sullivan, P. Clax, S. Huang, and J. D. Unadkat. “Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.” J Infect Dis 180, no. 5 (November 1999): 1536–41. https://doi.org/10.1086/315067.Full Text Link to Item
-
Raskino, C., D. A. Pearson, C. J. Baker, M. H. Lifschitz, K. O’Donnell, M. Mintz, M. Nozyce, et al. “Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team.” Pediatrics 104, no. 3 (September 1999): e32. https://doi.org/10.1542/peds.104.3.e32.Full Text Link to Item
-
Fiscus, S. A., A. A. Adimora, V. J. Schoenbach, R. McKinney, W. Lim, D. Rupar, J. Kenny, C. Woods, C. Wilfert, and V. A. Johnson. “Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina.” J Infect Dis 180, no. 1 (July 1999): 99–105. https://doi.org/10.1086/314840.Full Text Link to Item
-
Kline, M. W., R. B. Van Dyke, J. C. Lindsey, M. Gwynne, M. Culnane, C. Diaz, R. Yogev, R. E. McKinney, E. J. Abrams, and L. M. Mofenson. “Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team.” Pediatrics 103, no. 5 (May 1999): e62. https://doi.org/10.1542/peds.103.5.e62.Full Text Link to Item
-
Kline, M. W., S. Blanchard, C. V. Fletcher, J. L. Shenep, R. E. McKinney, R. C. Brundage, M. Culnane, et al. “A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team.” Pediatrics 103, no. 4 (April 1999): e47. https://doi.org/10.1542/peds.103.4.e47.Full Text Link to Item
-
Martel, Lisa A., Megan E. Valentine, Lori Ferguson, Penelope Muelenaer, Randall G. Fisher, Samuel L. Katz, and Ross E. McKinney. “Virologic and CD4 Response to Treatment with Nelfinavir in Therapy Experienced, Protease Inhibitor Naive HIV-Infected Children: 48 Week Follow-Up.” Pediatric Research 45, no. 4, Part 2 of 2 (April 1999): 168A-168A. https://doi.org/10.1203/00006450-199904020-00997.Full Text
-
McKinney, R. E., G. M. Johnson, K. Stanley, F. H. Yong, A. Keller, K. J. O’Donnell, P. Brouwers, et al. “A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.” J Pediatr 133, no. 4 (October 1998): 500–508. https://doi.org/10.1016/s0022-3476(98)70057-5.Full Text Link to Item
-
Swanson, D. S., X. Pan, M. W. Kline, R. E. McKinney, R. Yogev, L. L. Lewis, M. T. Brady, G. D. McSherry, W. M. Dankner, and J. M. Musser. “Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection.” J Infect Dis 178, no. 3 (September 1998): 776–82. https://doi.org/10.1086/515364.Full Text Link to Item
-
Carey, V. J., F. H. Yong, L. M. Frenkel, and R. E. McKinney. “Pediatric AIDS prognosis using somatic growth velocity.” Aids 12, no. 11 (July 30, 1998): 1361–69. https://doi.org/10.1097/00002030-199811000-00019.Full Text Link to Item
-
Wilfert, C. M., and R. E. McKinney. “When children harbor HIV.” Sci Am 279, no. 1 (July 1998): 94–95. https://doi.org/10.1038/scientificamerican0798-94.Full Text Link to Item
-
McKinney, R. E. “Combination antiretroviral therapy.” Pediatr Infect Dis J 17, no. 6 (June 1998): 515–16. https://doi.org/10.1097/00006454-199806000-00016.Full Text Link to Item
-
Kline, M. W., R. B. Van Dyke, J. C. Lindsey, M. Gwynne, M. Culnane, R. E. McKinney, S. Nichols, W. G. Mitchell, R. Yogev, and N. Hutcheon. “A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.” Pediatrics 101, no. 2 (February 1998): 214–20. https://doi.org/10.1542/peds.101.2.214.Full Text Link to Item
-
Valentine, M. E., C. R. Jackson, C. Vavro, C. M. Wilfert, D. McClernon, M. St Clair, S. L. Katz, and R. E. McKinney. “Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.” Pediatr Infect Dis J 17, no. 1 (January 1998): 18–23. https://doi.org/10.1097/00006454-199801000-00005.Full Text Link to Item
-
Englund, J. A., C. J. Baker, C. Raskino, R. E. McKinney, B. Petrie, M. G. Fowler, D. Pearson, et al. “Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.” N Engl J Med 336, no. 24 (June 12, 1997): 1704–12. https://doi.org/10.1056/NEJM199706123362403.Full Text Link to Item
-
Jackson, C. R., C. L. Vavro, M. E. Valentine, K. N. Pennington, E. R. Lanier, S. L. Katz, J. H. Diliberti, R. E. McKinney, C. M. Wilfert, and M. H. St Clair. “Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus.” Pediatr Infect Dis J 16, no. 2 (February 1997): 200–204. https://doi.org/10.1097/00006454-199702000-00007.Full Text Link to Item
-
Diliberti, J. H., M. E. Valentins, R. E. McKinney, and M. H. St Clair. “Stavudine(D4T, ZERIT™) sensitivities in clinical HIV isolates obtained from a pediatric population. Cynthia R Jackson 1,3 Cindy 1, Vayro 3.” Pediatric Aids and Hiv Infection 7, no. 4 (December 1, 1996): 283.
-
Englund, J. A., C. J. Baker, C. Raskino, R. E. McKinney, M. H. Lifschitz, B. Petrie, M. G. Fowler, et al. “Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team.” Pediatr Infect Dis J 15, no. 11 (November 1996): 1025–36. https://doi.org/10.1097/00006454-199611000-00018.Full Text Link to Item
-
Fiscus, S. A., A. A. Adimora, V. J. Schoenbach, W. Lim, R. McKinney, D. Rupar, J. Kenny, C. Woods, and C. Wilfert. “Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.” Jama 275, no. 19 (May 15, 1996): 1483–88.Link to Item
-
Jackson, C. R., C. L. Vavro, J. H. DiLiberti, M. E. Valentine, R. E. McKinney, and M. H. StClair. “Stavudine (D4T, ZERIT(TM)) sensitivities in clinical HIV isolates obtained from a pediatric population.” Pediatric Research 39, no. 4 (April 1, 1996): 1029–1029.Link to Item
-
Kimberlin, D., D. Powell, W. Gruber, P. Diaz, A. Arvin, M. Kumar, R. Jacobs, et al. “Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.” Pediatr Infect Dis J 15, no. 3 (March 1996): 247–54. https://doi.org/10.1097/00006454-199603000-00014.Full Text Link to Item
-
McKinney, R. E. “Antiretroviral therapy: evaluating the new era in HIV treatment.” Adv Pediatr Infect Dis 12 (1996): 297–323.Link to Item
-
McKinney, R. E. “Use of antiretroviral therapy in children and pregnant women.” Adv Exp Med Biol 394 (1996): 345–54. https://doi.org/10.1007/978-1-4757-9209-6_32.Full Text Link to Item
-
VAVRO, C. L., C. R. JACKSON, M. H. STCLAIR, K. N. PENNINGTON, E. R. LANIER, M. E. VALENTINE, and R. E. MCKINNEY. “A CLINICAL AND MOLECULAR CHARACTERIZATION OF LONG-TERM SURVIVAL IN PEDIATRIC HIV PATIENTS.” Journal of Cellular Biochemistry, April 2, 1995, 245–245.Link to Item
-
JACKSON, C. R., C. L. VAVRO, M. E. VALENTINE, R. E. MCKINNEY, and M. H. STCLAIR. “LONG-TERM SURVIVAL IN PEDIATRIC HIV.” Pediatric Research 37, no. 4 (April 1, 1995): A178–A178.Link to Item
-
MCKINNEY, R. E., R. WILFERT, and S. L. KATZ. “HEMATOLOGIC EFFECTS OF HIV-INFECTION IN CHILDREN LESS-THAN 2 YEARS OLD.” Pediatric Research 37, no. 4 (April 1, 1995): A183–A183.Link to Item
-
McKinney, R. E. “Growth delay, failure to thrive, and wasting in the HIV-infected child.” Seminars in Pediatric Infectious Diseases 6, no. 1 (January 1, 1995): 32–39. https://doi.org/10.1016/S1045-1870(05)80021-4.Full Text
-
McKinney, R. E., and C. Wilfert. “Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group.” J Pediatr 125, no. 5 Pt 1 (November 1994): 728–33. https://doi.org/10.1016/s0022-3476(94)70065-6.Full Text Link to Item
-
MCKINNEY, R. E. “MARKERS PROGNOSTIC FOR SURVIVAL IN ZIDOVUDINE TREATED, HIV-INFECTED CHILDREN.” Pediatric Research 35, no. 4 (April 1, 1994): A187–A187.Link to Item
-
VALENTINE, M., M. TRIPP, and R. E. MCKINNEY. “AN ASSOCIATION BETWEEN HIV-INFECTION, EPSTEIN-BARR-VIRUS (EBV) IMMUNE STATUS, CARDIOMYOPATHY, AND LYMPHOCYTIC INTERSTITIAL PNEUMONIA (LIP).” Pediatric Research 35, no. 4 (April 1, 1994): A199–A199.Link to Item
-
McKinney, R. E. “Growth and pediatric HIV infection.” Report on Pediatric Infectious Diseases 4, no. 4 (January 1, 1994): 14–15.
-
McKinney, R. E., and C. Wilfert. “Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine.” The Journal of Pediatrics 125, no. 5 PART 1 (January 1, 1994): 728–33. https://doi.org/10.1016/S0022-3476(06)80170-8.Full Text
-
Gellert, G., C. D. Berkowitz, L. T. Gutman, M. E. Herman-Giddens, and R. M. Jr. “Pediatric acquired immunodeficiency syndrome: Testing as a barrier to recognizing the role of child sexual abuse.” Archives of Pediatrics and Adolescent Medicine 148, no. 7 (1994): 766–68.
-
McKinney, R. E., and J. W. Robertson. “Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit.” J Pediatr 123, no. 4 (October 1993): 579–82. https://doi.org/10.1016/s0022-3476(05)80955-2.Full Text Link to Item
-
Gutman, L. T., M. E. Herman-Giddens, and R. E. McKinney. “Pediatric acquired immunodeficiency syndrome. Barriers to recognizing the role of child sexual abuse.” Am J Dis Child 147, no. 7 (July 1993): 775–80. https://doi.org/10.1001/archpedi.1993.02160310077023.Full Text Link to Item
-
Boucher, F. D., J. F. Modlin, S. Weller, A. Ruff, M. Mirochnick, S. Pelton, C. Wilfert, R. McKinney, M. J. Crain, and M. M. Elkins. “Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.” J Pediatr 122, no. 1 (January 1993): 137–44. https://doi.org/10.1016/s0022-3476(05)83507-3.Full Text Link to Item
-
Jr, R. E. M., J. Wesley, R. Robertson, and D. P. A. I. D. S. C. T. Unit. “Effect of human immunodeficiency virus infection on the growth of young children.” The Journal of Pediatrics 123, no. 4 (1993): 579–82.
-
Gutman, L. T., K. K. St Claire, C. Weedy, M. Herman-Giddens, and R. E. McKinney. “Sexual abuse of human immunodeficiency virus-positive children. Outcomes for perpetrators and evaluation of other household children.” Am J Dis Child 146, no. 10 (October 1992): 1185–89. https://doi.org/10.1001/archpedi.1992.02160220071025.Full Text Link to Item
-
McKinney, R. E., and C. M. Wilfert. “Lymphocyte subsets in children younger than 2 years old: normal values in a population at risk for human immunodeficiency virus infection and diagnostic and prognostic application to infected children.” Pediatr Infect Dis J 11, no. 8 (August 1992): 639–44.Link to Item
-
GRANT, C., R. E. MCKINNEY, C. WEEDY, S. L. KATZ, and C. M. WILFERT. “THE INTRODUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS INTO THE NORTH-CAROLINA PEDIATRIC POPULATION.” Pediatrics 90, no. 1 (July 1, 1992): 174–77.Link to Item
-
Grant, C., R. E. McKinney, C. Weedy, S. L. Katz, and C. M. Wilfert. “The introduction of human immunodeficiency virus into the North Carolina pediatric population.” Pediatrics 90, no. 1 Pt 2 (July 1992): 174–77.Link to Item
-
Maxeiner, H. G., K. O. Habermehl, T. Grünewald, and B. Ruf. “HIV-1 sensitivity to zidovudine and clinical outcome.” Lancet 339, no. 8793 (March 7, 1992): 626–27.Link to Item
-
Tudor-Williams, G., M. H. St Clair, R. E. McKinney, M. Maha, E. Walter, S. Santacroce, M. Mintz, K. O’Donnell, T. Rudoll, and C. L. Vavro. “HIV-1 sensitivity to zidovudine and clinical outcome in children.” Lancet 339, no. 8784 (January 4, 1992): 15–19. https://doi.org/10.1016/0140-6736(92)90140-x.Full Text Link to Item
-
Grant, C., R. E. McKinney, C. Weedy, S. L. Katz, and C. M. Wilfert. “The introduction of human immunodeficiency virus into the North Carolina pediatric population.” Pediatrics 90, no. 1 PART 2 (January 1, 1992): 174–77.
-
McKinney, R., and M. Maha. “How much zidovudine is safe for children with advanced HIV?” Rn 54, no. 7 (July 1991): 111.Link to Item
-
Walter, E. B., R. P. Drucker, R. E. McKinney, and C. M. Wilfert. “Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.” J Pediatr 119, no. 1 Pt 1 (July 1991): 152–55. https://doi.org/10.1016/s0022-3476(05)81057-1.Full Text Link to Item
-
McKinney, R. E., M. A. Maha, E. M. Connor, J. Feinberg, G. B. Scott, M. Wulfsohn, K. McIntosh, W. Borkowsky, J. F. Modlin, and P. Weintrub. “A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.” N Engl J Med 324, no. 15 (April 11, 1991): 1018–25. https://doi.org/10.1056/NEJM199104113241503.Full Text Link to Item
-
ODONNELL, K. J., M. I. MINTZ, M. A. MAHA, R. E. MCKINNEY, and C. M. WILFERT. “NEURODEVELOPMENTAL (ND) EFFECTS OF PEDIATRIC HIV-INFECTION AND TREATMENT WITH ORAL ZIDOVUDINE.” Pediatric Research 29, no. 4 (April 1, 1991): A181–A181.Link to Item
-
MCKINNEY, R. E., E. B. WALTER, G. TUDORWILLIAMS, S. L. KATZ, A. AUSTIN, and C. M. WILFERT. “CD-4+ LYMPHOCYTES IN CHILDREN UNDER 2-YEARS OLD - ESTABLISHMENT OF NORMAL VALUES IN A POPULATION AT RISK FOR HIV AND PROGNOSTIC APPLICATION TO INFECTED CHILDREN.” Pediatric Research 29, no. 4 (April 1, 1991): A178–A178.Link to Item
-
MCKINNEY, R. E., E. NOZIK, E. B. WALTER, G. TUDORWILLIAMS, S. L. KATZ, and C. M. WILFERT. “HEMATOLOGIC ABNORMALITIES IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED CHILDREN AND NONINFECTED BUT HIV ANTIBODY POSITIVE CONTROLS.” Pediatric Research 29, no. 4 (April 1, 1991): A178–A178.Link to Item
-
Gutman, L. T., K. K. St Claire, C. Weedy, M. E. Herman-Giddens, B. A. Lane, J. G. Niemeyer, and R. E. McKinney. “Human immunodeficiency virus transmission by child sexual abuse.” Am J Dis Child 145, no. 2 (February 1991): 137–41. https://doi.org/10.1001/archpedi.1991.02160020027008.Full Text Link to Item
-
McKinney, R. E. “Antiviral therapy for human immunodeficiency virus infection in children.” Pediatr Clin North Am 38, no. 1 (February 1991): 133–51. https://doi.org/10.1016/s0031-3955(16)38047-6.Full Text Link to Item
-
Jr, R. E. M., M. A. Maha, E. M. Connor, J. Feinberg, G. B. Scott, M. Wulfsohn, K. McIntosh, et al. “A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease.” New England Journal of Medicine 324, no. 15 (1991): 1018–25.
-
McKinney Jnr., R. E. “Vertically transmitted human immunodeficiency virus infection.” Current Opinion in Infectious Diseases 4, no. 4 (January 1, 1991): 469–73. https://doi.org/10.1097/00001432-199108000-00003.Full Text
-
Monteleone, J. A., L. T. Gutman, K. S. Claire, M. Herman-Giddens, and R. E. M. Jr. “Child sexual abuse and human immunodeficiency virus transmission [6].” American Journal of Diseases of Children 145, no. 8 (1991): 847–48.
-
Gutman, L. T., K. Claire, M. Herman-Giddens, and R. E. McKinney. “In Reply.” American Journal of Diseases of Children 145, no. 8 (January 1, 1991): 847–48. https://doi.org/10.1001/archpedi.1991.02160080021009.Full Text
-
Walter, E. B., R. E. McKinney, B. A. Lane, K. J. Weinhold, and C. M. Wilfert. “Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis.” J Pediatr 117, no. 2 Pt 1 (August 1990): 255–58. https://doi.org/10.1016/s0022-3476(05)80540-2.Full Text Link to Item
-
Walter, E. B., J. L. Gingras, and R. E. McKinney. “Systemic Torulopsis glabrata infection in a neonate.” South Med J 83, no. 7 (July 1990): 837–38. https://doi.org/10.1097/00007611-199007000-00027.Full Text Link to Item
-
GUTMAN, L. T., K. K. STCLAIRE, C. WEEDY, M. E. HERMANGIDDENS, B. A. LANE, and R. E. MCKINNEY. “THE EPIDEMIOLOGIC INTERSECTION IN CHILDREN OF SEXUAL ABUSE AND AIDS.” Pediatric Research 27, no. 4 (April 1, 1990): A172–A172.Link to Item
-
McKinney, R. E., P. A. Pizzo, G. B. Scott, W. P. Parks, M. A. Maha, S. N. Lehrman, M. Riggs, J. Eddy, B. A. Lane, and S. C. Eppes. “Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.” J Pediatr 116, no. 4 (April 1990): 640–47. https://doi.org/10.1016/s0022-3476(05)81619-1.Full Text Link to Item
-
Balis, F. M., P. A. Pizzo, J. Eddy, C. Wilfert, R. McKinney, G. Scott, R. F. Murphy, P. F. Jarosinski, J. Falloon, and D. G. Poplack. “Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.” J Pediatr 114, no. 5 (May 1989): 880–84. https://doi.org/10.1016/s0022-3476(89)80158-1.Full Text Link to Item
-
Wilfert, C. M., and R. McKinney. “Treatment of children symptomatic with human immunodeficiency virus infection.” J Infect 18 Suppl 1 (January 1989): 81–82. https://doi.org/10.1016/s0163-4453(89)80085-4.Full Text Link to Item
-
Siddique, T., R. McKinney, W. Y. Hung, R. J. Bartlett, G. Bruns, T. K. Mohandas, H. H. Ropers, C. Wilfert, and A. D. Roses. “The poliovirus sensitivity (PVS) gene is on chromosome 19q12----q13.2.” Genomics 3, no. 2 (August 1988): 156–60. https://doi.org/10.1016/0888-7543(88)90147-4.Full Text Link to Item
-
McKinney, R. E., S. L. Katz, and C. M. Wilfert. “Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.” Rev Infect Dis 9, no. 2 (March 1987): 334–56. https://doi.org/10.1093/clinids/9.2.334.Full Text Link to Item
-
MCKINNEY, R. E., M. L. MARKERT, L. W. WILLIAMS, R. H. BUCKLEY, and C. M. WILFERT. “THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) PREPARATIONS IN THE TREATMENT OF CHRONIC ENTEROVIRAL INFECTIONS.” Pediatric Research 20, no. 4 (April 1, 1986): A297–A297.Link to Item
-
MCKINNEY, R. E., S. E. SCHIFF, C. M. WILFERT, J. R. SHERWOOD, R. L. WARD, D. I. BERNSTEIN, and G. M. SCHIFF. “CELL-MEDIATED IMMUNE (CMI) RESPONSE TO ECHOVIRUS 12 (E12) INFECTION IN HUMANS.” Pediatric Research 20, no. 4 (April 1, 1986): A297–A297.Link to Item
-
MCKINNEY, R. E., and C. M. WILFERT. “CLINICAL SUMMARY OF 41 PATIENTS WITH CHRONIC ENTEROVIRAL MENINGOENCEPHALITIS AND AGAMMAGLOBULINEMIA (CEMA).” Pediatric Research 20, no. 4 (April 1, 1986): A316–A316.Link to Item
-
Hellquist, Joan M., Ross E. McKinney, and Gordon Worley. “1110 URINARY TRACT INFECTIONS IN CEREBRAL PALSY PATIENTS.” Pediatric Research 19, no. 4 (April 1985): 295A-295A. https://doi.org/10.1203/00006450-198504000-01140.Full Text
-
McKinney, Ross E., Thomas J. Maroon, and Catherine M. Wilfert. “1140 THE EFFECT OF AN ANTIVIRAL AGENT (WIN 51,711) ON COXSACKIEVIRUS A9 INFECTION IN SUCKLING MICE.” Pediatric Research 19, no. 4 (April 1985): 300A-300A. https://doi.org/10.1203/00006450-198504000-01170.Full Text
-
McKinney, R. E. “Hemolytic-uremic syndrome and Entamoeba histolytica infection.” Pediatr Infect Dis 3, no. 4 (July 1984): 371. https://doi.org/10.1097/00006454-198407000-00024.Full Text Link to Item
-
Hodgman, C. H., E. R. McAnarney, G. J. Myers, H. Iker, R. McKinney, D. Parmelee, B. Schuster, and M. Tutihasi. “Emotional complications of adolescent grand mal epilepsy.” J Pediatr 95, no. 2 (August 1979): 309–12. https://doi.org/10.1016/s0022-3476(79)80680-0.Full Text Link to Item
-
Hodgman, C. H., E. R. McAnarney, G. J. Myers, H. Iker, R. McKinney, D. Parmelee, B. Schuster, and M. Tutihasi. “Emotional complications of adolescent grand mal epilepsy.” Journal of Pediatrics 95, no. 2 (1979): 309–12. https://doi.org/10.1016/S0022-3476(79)80682-4.Full Text
-
-
Book Sections
-
McKinney, R. E. “Medical ethics.” In AAOS Comprehensive Orthopaedic Review 2, 1:249–54, 2018.
-
Lantos, P. M., and R. E. McKinney. “Rickettsial and Ehrlichial Diseases.” In Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, edited by James Cherry, Gail J. Demmler-Harrison, Sheldon L. Kaplan, William J. Steinbach, and Peter J. Hotez. W B Saunders Company, 2013.
-
-
Conference Papers
-
McKinney, R. E., M. L. S. Cruz, C. Powell, M. Hughes, J. M. Oleske, H. Winter, C. Elgie, et al. “International formula-based nutritional intervention for infants born to HIV-infected women.” In Pediatric Research, 55:XLIII–XLIII. INT PEDIATRIC RESEARCH FOUNDATION, INC, 2004.Link to Item
-
McKinney, R. E., M. L. S. Cruz, C. Powell, M. Hughes, J. M. Oleske, H. Winter, C. Elgie, et al. “International formula-based nutritional intervention for infants born to HIV-infected women.” In Pediatric Research, 55:ER43–ER43. INT PEDIATRIC RESEARCH FOUNDATION, INC, 2004.Link to Item
-
Fisher, R. G., M. E. Tabangin, S. Nageswaran, and R. E. McKinney. “Hospitalization trends among pediatric patients with HIV infection and acquired immunodeficiency syndrome.” In Pediatric Research, 53:332A-332A. INT PEDIATRIC RESEARCH FOUNDATION, INC, 2003.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.